Campomelic Dysplasia
Also known as: CMD1, Campomelic syndrome, Camptomelic dysplasia
Campomelic dysplasia (CMD) is a rare, severe skeletal dysplasia characterized by bowing of the long bones, particularly the femurs and tibias (campomelia), and a high rate of male-to-female sex reversal in individuals with a 46,XY karyotype. It is often associated with respiratory distress and other life-threatening complications in infancy.
Campomelic dysplasia is a rare condition where babies are born with bent bones, breathing problems, and sometimes, boys can look like girls. It's very serious, and many babies don't live long, but doctors try to help them breathe and fix their bones.
Signs & Symptoms
- Bowing of long bones (especially femurs and tibias)
- Male-to-female sex reversal in 46,XY individuals
- Hypoplastic scapulae
- Clubfoot
- Bell-shaped thorax
- Respiratory distress
- Cleft palate
- Micrognathia (small jaw)
- Hydrocephalus
- Scoliosis
- Hearing loss
- Facial dysmorphism (e.g., prominent forehead, hypertelorism)
Treatment Options
Respiratory Support
SUPPORTIVESurgical Correction of Skeletal Deformities
MODERATELY EFFECTIVEManagement of Cleft Palate
HIGHLY EFFECTIVEHearing Aids/Cochlear Implants
MODERATELY EFFECTIVEPhysical Therapy
SUPPORTIVEDiagnosis
- Prenatal ultrasound
- Postnatal radiographic examination
- Genetic testing (SOX9 gene sequencing)
- Physical examination
History
Campomelic dysplasia was first described in the early 1970s. The identification of SOX9 as the causative gene in the 1990s significantly advanced our understanding of the pathogenesis of this condition.
Recent Breakthroughs
Advances in Understanding SOX9 Regulation
Recent research has focused on the complex regulatory mechanisms controlling SOX9 expression, providing insights into the variable expressivity of campomelic dysplasia and potential therapeutic targets.
Improved Respiratory Management Strategies
Novel approaches to respiratory management, including high-frequency oscillatory ventilation and early tracheostomy, have shown promise in improving survival rates in infants with campomelic dysplasia.